Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 506450, 12 pages
http://dx.doi.org/10.1155/2014/506450
Research Article

TRPV1 Antagonism by Capsazepine Modulates Innate Immune Response in Mice Infected with Plasmodium berghei ANKA

1Universidade CEUMA, 65075-120 São Luís, MA, Brazil
2Cardiovascular Division, King’s College London, London, UK
3Universidade de São Paulo, São Paulo, Brazil
4Universidade Federal de São Paulo, Diadema, Brazil
5Universidade Federal do Maranhão, São Luís, Brazil
6Instituto Florence de Ensino Superior, São Luís, Brazil

Received 3 June 2014; Accepted 8 July 2014; Published 24 August 2014

Academic Editor: Mauricio Martins Rodrigues

Copyright © 2014 Elizabeth S. Fernandes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, World Malaria Report: 2013, 2013.
  2. L. Schofield, “Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis,” Immunology and Cell Biology, vol. 85, no. 2, pp. 130–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Pradhan and K. Ghosh, “Immunological disturbances associated with malarial infection,” Journal of Parasitic Diseases, vol. 37, no. 1, pp. 11–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Shikani, B. D. Freeman, M. P. Lisanti, L. M. Weiss, H. B. Tanowitz, and M. S. Desruisseaux, “Cerebral malaria: we have come a long way,” The American Journal of Pathology, vol. 181, no. 5, pp. 1484–1492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Moulick, S. Maitra, B. S. Sarkar, A. Jana, and S. Sarkar, “Vivax malaria presenting with myelitis: a rare complication,” Journal of Clinical and Diagnostic Research, vol. 7, no. 5, pp. 914–916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Stevenson and E. M. Riley, “Innate immunity to malaria,” Nature Reviews Immunology, vol. 4, no. 3, pp. 169–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. I. A. Clark, “How TNF was recognized as a key mechanism of disease,” Cytokine and Growth Factor Reviews, vol. 18, no. 3-4, pp. 335–343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Fernandes, M. A. Fernandes, and J. E. Keeble, “The functions of TRPA1 and TRPV1: moving away from sensory nerves,” British Journal of Pharmacology, vol. 166, no. 2, pp. 510–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. S. Fernandes, L. Liang, S. Smillie et al., “TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome,” Journal of Immunology, vol. 188, no. 11, pp. 5741–5751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Guptill, X. Cui, A. Khaibullina et al., “Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis,” Anesthesiology, vol. 114, no. 5, pp. 1190–1199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Susankova, K. Tousova, L. Vyklicky, J. Teisinger, and V. Vlachova, “Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current,” Molecular Pharmacology, vol. 70, no. 1, pp. 383–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. S. Fernandes, C. T. Vong, S. Quek et al., “Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B4-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1,” The FASEB Journal, vol. 27, no. 4, pp. 1664–1673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Puntambekar, D. Mukherjea, S. Jajoo, and V. Ramkumar, “Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression,” Journal of Neurochemistry, vol. 95, no. 6, pp. 1689–1703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Starr, R. Graepel, J. Keeble et al., “A reactive oxygen species-mediated component in neurogenic vasodilatation,” Cardiovascular Research, vol. 78, no. 1, pp. 139–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. K. B. Ferrari, P. C. S. Souto, E. L. França, and A. C. Honorio-França, “Oxidative and nitrosative stress on phagocytes' function: from effective defense to immunity evasion mechanisms,” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 6, pp. 441–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Percário, D. R. Moreira, B. A. Q. Gomes et al., “Oxidative stress in Malaria,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 16346–16372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. R. M. Elias, M. Correa-Costa, C. R. Barreto et al., “Oxidative stress and modification of renal vascular permeability are associated with acute kidney injury during P. berghei ANKA infection,” PLoS ONE, vol. 7, no. 8, Article ID e44004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. S. Hansen, N. J. Bernard, C. Q. Nie, and L. Scholeld, “NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria,” Journal of Immunology, vol. 178, no. 9, pp. 5779–5788, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Rénia, S. W. Howland, C. Claser et al., “Cerebral malaria Mysteries at the blood-brain barrier,” Virulence, vol. 3, no. 2, pp. 193–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. Bird and H. H. Draper, “Comparative studies on different methods of malonaldehyde determination,” Methods in Enzymology, vol. 105, pp. 299–305, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Sharma, J. Kaur, and G. Shukla, “Role of oxidative stress and apoptosis in the placental pathology of plasmodium berghei infected mice,” PLoS ONE, vol. 7, no. 3, Article ID e32694, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Nassini, P. Pedretti, N. Moretto et al., “Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation,” PLoS ONE, vol. 7, no. 8, Article ID e42454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Tsuji and H. Aono, “Role of transient receptor potential vanilloid 1 in inflammation and autoimmune diseases,” Pharmaceuticals, vol. 5, no. 8, pp. 837–852, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Yang, H. M. Yu, X. D. Zhou, V. P. Kolosov, and J. M. Perelman, “Study on TRPV1-mediated mechanism for the hypersecretion of mucus in respiratory inflammation,” Molecular Immunology, vol. 53, no. 1-2, pp. 161–171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. S. Fernandes, F. A. Russell, D. Spina et al., “A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis,” Arthritis and Rheumatism, vol. 63, no. 3, pp. 819–829, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Keeble, F. Russell, B. Curtis, A. Starr, E. Pinter, and S. D. Brain, “Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3248–3256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F. A. Russell, E. S. Fernandes, J. Courade, J. E. Keeble, and S. D. Brain, “Tumour necrosis factor α mediates transient receptor potential vanilloid 1-dependent bilateral thermal hyperalgesia with distinct peripheral roles of interleukin-1β, protein kinase C and cyclooxygenase-2 signalling,” Pain, vol. 142, no. 3, pp. 264–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. K. Finney-Hayward, M. O. Popa, P. Bahra et al., “Expression of transient receptor potential C6 channels in human lung macrophages,” The American Journal of Respiratory Cell and Molecular Biology, vol. 43, no. 3, pp. 296–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. I. Saunders, R. G. Fassett, and D. P. Geraghty, “Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1792, no. 10, pp. 1019–1026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zhao, L. Ching, Y. R. Kou et al., “Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-Induced inflammation in macrophages: role of liver X receptor α,” Mediators of Inflammation, vol. 2013, Article ID 925171, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Bryant, M. Shumate, G. Yumet, C. H. Lang, T. C. Vary, and R. N. Cooney, “Capsaicin-sensitive nerves regulate the metabolic response to abdominal sepsis,” The Journal of Surgical Research, vol. 112, no. 2, pp. 152–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Clark, J. Keeble, E. S. Fernandes et al., “The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin,” The FASEB Journal, vol. 21, no. 13, pp. 3747–3755, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Iida, I. Shimizu, M. L. Nealen, A. Campbell, and M. Caterina, “Attenuated fever response in mice lacking TRPV1,” Neuroscience Letters, vol. 378, no. 1, pp. 28–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wang, M. Novotný, V. Quaiserová-Mocko, G. M. Swain, and D. H. Wang, “TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 294, no. 5, pp. R1517–R1523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. R. J. Docherty, J. C. Yeats, and A. S. Piper, “Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture,” British Journal of Pharmacology, vol. 121, no. 7, pp. 1461–1467, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Liu and S. A. Simon, “Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia,” Neuroscience Letters, vol. 228, no. 1, pp. 29–32, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. C. H. Gill, P. J. Strijbos, S. A. Bates, W. Cairns, D. Owen, and C. H. Davies, “Capsazepine inhibits a recombinant human HCN1-mediated current,” British Journal of Pharmacology, vol. 135, no. 5, p. 251, 2001. View at Google Scholar
  38. P. McIntyre, L. M. McLatchie, A. Chambers et al., “Pharmacological differences between the human and rat vanilloid receptor 1 (VR1),” British Journal of Pharmacology, vol. 132, no. 5, pp. 1084–1094, 2001. View at Google Scholar · View at Scopus
  39. U. Frevert and A. Nacer, “Immunobiology of Plasmodium in liver and brain,” Parasite Immunology, vol. 35, no. 9-10, pp. 267–282, 2013. View at Google Scholar
  40. C. Coban, K. J. Ishii, T. Horii, and S. Akira, “Manipulation of host innate immune responses by the malaria parasite,” Trends in Microbiology, vol. 15, no. 6, pp. 271–278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Gallo, O. A. Skorokhod, E. Schwarzer, and P. Arese, “Simultaneous determination of phagocytosis of Plasmodium falciparum-parasitized and non-parasitized red blood cells by flow cytometry,” Malaria Journal, vol. 11, article 428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F. M. S. de Leoratti, S. C. Trevelin, F. Q. Cunha et al., “Neutrophil paralysis in Plasmodium vivax malaria,” PLoS Neglected Tropical Diseases, vol. 6, no. 6, Article ID e1710, p. e1710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. C. L. L. Chua, G. Brown, J. A. Hamilton, S. Rogerson, and P. Boeuf, “Monocytes and macrophages in malaria: protection or pathology?” Trends in Parasitology, vol. 29, no. 1, pp. 26–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. Fischer, M. L. Davies, I. E. Reider et al., “CD11b+, Ly6G+ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection,” PLoS Pathogens, vol. 7, no. 11, Article ID e1002374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. Villadangos, “Hold On, the Monocytes Are Coming!,” Immunity, vol. 26, no. 4, pp. 390–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Q. Yang, P. Ghose, and N. Ismaila, “Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced Toxic Shock,” Infection and Immunity, vol. 81, no. 5, pp. 1751–1763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. N. Fullerton, A. J. O'Brien, and D. W. Gilroy, “Pathways mediating resolution of inflammation: when enough is too much,” The Journal of Pathology, vol. 231, no. 1, pp. 8–20, 2013. View at Google Scholar
  48. J. A. van Ginderachter, A. Beschin, P. D. Baetselier, and G. Raes, “Myeloid-derived suppressor cells in parasitic infections,” European Journal of Immunology, vol. 40, no. 11, pp. 2976–2985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. I. Gabrilovich and S. Nagaraj, “Myeloid-derived suppressor cells as regulators of the immune system,” Nature Reviews Immunology, vol. 9, no. 3, pp. 162–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. K. E. Lyke, R. Burges, Y. Cissoko et al., “Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls,” Infection and Immunity, vol. 72, no. 10, pp. 5630–5637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. S. L. Hazen, “Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity,” Journal of Biological Chemistry, vol. 283, no. 23, pp. 15527–15531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Schwarzer, H. Kühn, E. Valente, and P. Arese, “Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions,” Blood, vol. 101, no. 2, pp. 722–728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Vitale, M. Della Chiesa, S. Carlomagno et al., “NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor,” Blood, vol. 106, no. 2, pp. 566–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Gimenez, S. B. De Lagerie, C. Fernandez, P. Pino, and D. Mazier, “Tumor necrosis factor α in the pathogenesis of cerebral malaria,” Cellular and Molecular Life Sciences, vol. 60, no. 8, pp. 1623–1635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. J. Garle, A. Knight, A. T. Downing, K. L. Jassi, R. H. Clothier, and J. R. Fry, “Stimulation of dichlorofluorescin oxidation by capsaicin and analogues in RAW 264 monocyte/macrophages: lack of involvement of the vanilloid receptor,” Biochemical Pharmacology, vol. 59, no. 5, pp. 563–572, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Schilling and C. Eder, “Importance of the non-selective cation channel TRPV1 for microglial reactive oxygen species generation,” Journal of Neuroimmunology, vol. 216, no. 1-2, pp. 118–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri, “Reciprocal activating interaction between natural killer cells and dendritic cells,” The Journal of Experimental Medicine, vol. 195, no. 3, pp. 327–333, 2002. View at Publisher · View at Google Scholar · View at Scopus